News

Despite concerns raised by clinicians and ethicists, direct-to-consumer testing for Alzheimer’s disease biomarkers is here, ...
This was the stock's second consecutive day of losses.
Quest Diagnostics Inc. closed 5.99% below its 52-week high of $182.38, which the company achieved on June 16th.
Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts. On June ...
While DGX stock has been hammered in the market recently, the smart money may be sensing a bounce-back opportunity.
Many men run to get their testosterone checked, only to learn their symptoms are due to a different issue. This urologist ...
IF YOU KNOW you’ve been exposed to something potentially toxic, seek emergency medical care. Some signs that this may have ...
The lining on the inside of a nonstick pan is made of plastic. When heated, it can release toxic fumes; when scratched, it ...
The Durham-based parent company says it still plans to grow Q2 Solutions’ local headcount despite the grant terminations.
Anubha Gaur transforms healthcare tech! She leads DevSecOps & SRE, emphasizing culture over tools for secure, reliable ...
Forget what the experience designation next to Abdul Carter says; the NY Giants rookie is fired up and ready to wreck opposing offenses.
Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance earlier this year. | The Lumipulse G blood test measures the ratio between ...